NCT/Study#

MAGE-A4

AN OPEN-LABEL, MULTICENTER, DOSE-ESCALATION, PHASE I STUDY TO EVALUATE SAFETY, PHARMACOKINETICS, AND PRELIMINARY ANTI-TUMOR ACTIVITY OF RO7444973 IN PARTICIPANTS WITH ADVANCED AND/OR METASTATIC MAGE A4-POSITIVE, SOLID TUMORS.

AN OPEN-LABEL, MULTICENTER, DOSE-ESCALATION, PHASE I STUDY TO EVALUATE SAFETY, PHARMACOKINETICS, AND PRELIMINARY ANTI-TUMOR ACTIVITY OF RO7444973 IN PARTICIPANTS WITH ADVANCED AND/OR METASTATIC MAGE A4-POSITIVE, SOLID TUMORS.

DISEASE GROUP:
Phase 1
current phase:
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: